Kristin Stephens

Corporate Officer/Principal at SYROS PHARMACEUTICALS, INC.

53 year

Health Technology

Consumer Services

Profile

Kristin Stephens is currently the Chief Development Officer at Syros Pharmaceuticals, Inc. She previously worked as the Vice President-Global Clinical Operations at Millennium Pharmaceuticals, Inc. and as a Vice President at Takeda Pharmaceuticals U.S.A., Inc. She completed her undergraduate degree at Hobart & William Smith Colleges.

Kristin Stephens active positions

Companies	Position	Start
SYROS PHARMACEUTICALS, INC.	Corporate Officer/Principal	2018-02-28

All active positions of Kristin Stephens

Former positions of Kristin Stephens

Companies	Position	End
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Corporate Officer/Principal	-
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Corporate Officer/Principal	-

See the detail of Kristin Stephens's experience

Education of Kristin Stephens

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kristin Stephens's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Health Technology
Hobart & William Smith Colleges Hobart & William Smith Colleges Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies	Health Technology